Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionaspartic-type endopeptidase activity

ERVK-7 ERVK-21 ERVK-9 ERVK-24

2.53e-0637524GO:0004190
GeneOntologyMolecularFunctionaspartic-type peptidase activity

ERVK-7 ERVK-21 ERVK-9 ERVK-24

2.83e-0638524GO:0070001
GeneOntologyMolecularFunctionglycosyltransferase activity

POMT2 TMEM260 B3GNT2 WDFY3 B4GALNT3 PARP12

9.97e-05288526GO:0016757
GeneOntologyMolecularFunctiondolichyl-phosphate-mannose-protein mannosyltransferase activity

POMT2 TMEM260

1.84e-048522GO:0004169
GeneOntologyMolecularFunctionhexosyltransferase activity

POMT2 TMEM260 B3GNT2 WDFY3 B4GALNT3

2.18e-04211525GO:0016758
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DNAH3 DNAH2

9.91e-0418522GO:0008569
GeneOntologyCellularComponentcortical endoplasmic reticulum

ASPH OSBPL8

2.16e-049522GO:0032541
GeneOntologyCellularComponentinner dynein arm

DNAH3 DNAH2

2.70e-0410522GO:0036156
DomainBROMODOMAIN_2

BPTF BRDT KMT2A

1.59e-0441483PS50014
DomainBROMO

BPTF BRDT KMT2A

1.70e-0442483SM00297
DomainBromodomain

BPTF BRDT KMT2A

1.70e-0442483IPR001487
Domain-

BPTF BRDT KMT2A

1.70e-04424831.20.920.10
DomainSH3

AHI1 MPP4 SGSM3 NEB ITK

2.26e-04216485SM00326
DomainSH3

AHI1 MPP4 SGSM3 NEB ITK

2.26e-04216485PS50002
DomainSH3_domain

AHI1 MPP4 SGSM3 NEB ITK

2.46e-04220485IPR001452
DomainDynein_heavy_chain_D4_dom

DNAH3 DNAH2

5.77e-0414482IPR024317
DomainDynein_HC_stalk

DNAH3 DNAH2

5.77e-0414482IPR024743
DomainDynein_heavy_dom-2

DNAH3 DNAH2

5.77e-0414482IPR013602
DomainDHC_N2

DNAH3 DNAH2

5.77e-0414482PF08393
DomainMT

DNAH3 DNAH2

5.77e-0414482PF12777
DomainAAA_8

DNAH3 DNAH2

5.77e-0414482PF12780
DomainATPase_dyneun-rel_AAA

DNAH3 DNAH2

5.77e-0414482IPR011704
DomainAAA_5

DNAH3 DNAH2

5.77e-0414482PF07728
DomainDHC_fam

DNAH3 DNAH2

6.65e-0415482IPR026983
DomainDynein_heavy_dom

DNAH3 DNAH2

6.65e-0415482IPR004273
DomainDynein_heavy

DNAH3 DNAH2

6.65e-0415482PF03028
DomainSH3_1

AHI1 SGSM3 NEB ITK

8.25e-04164484PF00018
DomainWGR_domain

PI4K2A PARP12

1.72e-0324482IPR008893
DomainBromodomain_CS

BPTF BRDT

2.02e-0326482IPR018359
DomainGPCR_2_secretin-like_CS

GCGR ADGRD1

3.44e-0334482IPR017983
DomainBROMODOMAIN_1

BPTF BRDT

4.07e-0337482PS00633
DomainBromodomain

BPTF BRDT

4.29e-0338482PF00439
DomainG_PROTEIN_RECEP_F2_1

GCGR ADGRD1

4.74e-0340482PS00649
DomainGPCR_2_extracellular_dom

GCGR ADGRD1

4.74e-0340482IPR001879
DomainG_PROTEIN_RECEP_F2_3

GCGR ADGRD1

4.74e-0340482PS50227
DomainZnf_FYVE_PHD

BPTF KMT2A WDFY3

6.38e-03147483IPR011011
DomainG_PROTEIN_RECEP_F2_2

GCGR ADGRD1

7.32e-0350482PS00650
Domain7tm_2

GCGR ADGRD1

7.32e-0350482PF00002
Pubmed

A revised nomenclature for transcribed human endogenous retroviral loci.

ERVK-5 ERVK-7 ERVK-21 ERVK-9 ERVK-24

3.04e-079452521542922
Pubmed

Positive regulation of Itk PH domain function by soluble IP4.

ITK ITPKB

2.19e-06252217412921
Pubmed

Identification of 2 Potentially Relevant Gene Mutations Involved in Strabismus Using Whole-Exome Sequencing.

AHI1 NEB

2.19e-06252228391287
Pubmed

Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.

ERVK-21 ERVK-9 ERVK-24

2.53e-061852318664271
Pubmed

Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

ERVK-7 ERVK-24

1.31e-05452210469592
Pubmed

A new sodium channel alpha-subunit gene (Scn9a) from Schwann cells maps to the Scn1a, Scn2a, Scn3a cluster of mouse chromosome 2.

SCN9A NEB

2.19e-0555228812438
Pubmed

Quantitation of HERV-K env gene expression and splicing in human breast cancer.

ERVK-7 ERVK-21

2.19e-05552212629516
Pubmed

Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.

ERVK-5 ERVK-7

2.19e-05552211401426
Pubmed

Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

XIAP ITK

3.28e-05652221674762
Pubmed

Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.

DNAH3 DNAH2

4.58e-0575229256245
Pubmed

Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

B3GNT2 IL23R

7.84e-05952220062062
Pubmed

Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.

ERVK-21 ERVK-9

1.43e-041252214557543
Pubmed

A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa.

NTNG1 OPRD1

1.69e-041352221079607
Pubmed

Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.

DNAH3 DNAH2

1.97e-04145229373155
Pubmed

Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.

BPTF BRDT KMT2A

1.97e-047552325593309
Pubmed

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease.

RNASE2 IL23R

2.94e-041752220570966
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

DNAH2 ELP1 WDFY3 NEB ACSS3 ITPKB

3.70e-0463852631182584
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

BRDT B3GNT2 DNAH2 KMT2A XIAP ITK

7.50e-0473052634857952
Pubmed

NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure.

AHI1 SCN9A

7.51e-042752223359859
Pubmed

Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.

NEB ITK

8.08e-042852218067320
Pubmed

JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis.

BRDT NAT8

8.67e-042952227649575
Pubmed

Integrating genetic and network analysis to characterize genes related to mouse weight.

PI4K2A NEB

8.67e-042952216934000
Pubmed

Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.

AHI1 NTNG1

1.41e-033752226951610
GeneFamilyDyneins, axonemal

DNAH3 DNAH2

4.32e-0417332536
GeneFamilyPHD finger proteins

BPTF KMT2A

1.17e-029033288
CoexpressionJOHNSTONE_PARVB_TARGETS_1_DN

KIAA0232 WDFY3 DCAF16 STEAP1

5.33e-0664474M2237
CoexpressionJNK_DN.V1_DN

ZNF549 NAT8 KMT2A GCGR STEAP1

2.27e-05190475M2745
CoexpressionMCBRYAN_PUBERTAL_BREAST_3_4WK_UP

PTPN5 BMP1 MFGE8 RNASE2 ADGRD1

4.02e-05214475M13186
CoexpressionMCBRYAN_PUBERTAL_BREAST_3_4WK_UP

PTPN5 BMP1 MFGE8 RNASE2 ADGRD1

5.66e-05230475MM986
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN5 NTNG1 NEB IL23R ITK

1.23e-06178475888add8935ef3aef9b6693c5698e9d1842e66337
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN5 NTNG1 NEB IL23R ITK

1.23e-0617847543eda32af2e5e28a92421612d0a4c21e5427a772
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DNAH3 DNAH2 SLC13A3 OPRD1

2.88e-051674743edb0570e583bb527165bcd8a4c25a042054043b
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B3GNT2 NTNG1 NEB ITK

3.24e-051724743acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

B3GNT2 NTNG1 NEB ITK

3.24e-051724744d04df9776394ea156ed5822f92ae74fdefbaa3d
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass

OSBPL8 WDFY3 NEB STEAP1

3.31e-0517347442c911ed16fabdabef063830e8407192d8bde950
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B3GNT2 NTNG1 NEB ITK

3.46e-051754743bdccb4037053795d62ab5b6fcc09cdd406f9b50
ToppCelldroplet-Lung-30m-Hematologic-lymphocytic-regulatory_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

B3GNT2 NTNG1 NEB ITK

3.46e-05175474770546ddaa49ee482c4c7577ab76efbc6c304a29
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MPP4 SCN9A GCGR OPRD1

3.54e-05176474116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MPP4 SCN9A GCGR OPRD1

3.54e-051764745b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PI4K2A IL23R ITK ITPKB

3.86e-051804745c649e2b3f5a53c0040b69df6e289fb3427ef2db
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFGE8 KIAA0232 GCGR ERMP1

4.03e-05182474ccfee33de0faebbe69099d4ff3c3971f6a708b99
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MFGE8 NAAA NAT8 SLC13A3

4.39e-05186474ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGSF10 BMP1 ADGRD1 STEAP1

5.07e-05193474316ebdf15f75d88c348f909b643fcd315364ca84
ToppCelldroplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGSF10 BMP1 ADGRD1 STEAP1

5.07e-051934741afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCelldroplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGSF10 BMP1 ADGRD1 STEAP1

5.07e-051934748dc6db335678f3a5cfd36026ad811fed8d9cb4bc
ToppCellfacs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGSF10 BMP1 ASPH ADGRD1

5.38e-05196474b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCellfacs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IGSF10 BMP1 ASPH ADGRD1

5.38e-05196474787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

BMP1 MFGE8 B4GALNT3 STEAP1

5.60e-05198474eb78b2ae6a787dbc75947e8dd5a03693285bc8be
ToppCellBronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

BMP1 MFGE8 ADGRD1 STEAP1

5.82e-05200474b04831708fa20471a127b87e8db3728b6e729ce8
ToppCellSepsis-Bac-SEP-Lymphocyte-T/NK-NK_CD56bright|Bac-SEP / Disease, condition lineage and cell class

KMT2A SGSM3 B4GALNT3 IL23R

5.82e-05200474ebab762fe5209c23c5a9ac9281f728fafa433af3
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

MFGE8 AHI1 ASPH PI4K2A KMT2A SGSM3 ACSS3

1.53e-071974773748_DN
DrugSB 203580; Up 200; 1uM; PC3; HT_HG-U133A

POMT2 BMP1 AHI1 NAAA SGSM3 WDFY3 ITK

1.53e-071974777066_UP
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

MFGE8 ASPH SCN9A ELP1 SGSM3 WDFY3

3.02e-061964765757_DN
DrugRauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; PC3; HT_HG-U133A

POMT2 BMP1 AHI1 NAAA ELP1 WDFY3

3.11e-061974765800_DN
DrugCarteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

NAAA ASPH PI4K2A SGSM3 WDFY3 PARP12

3.20e-061984763276_UP
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

TMEM260 BPTF ASPH KMT2A DCAF16

3.25e-051784753998_DN
Drugpioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A

AHI1 B3GNT2 SCN9A WDFY3 ITK

4.77e-051934756893_UP
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; PC3; HT_HG-U133A

BMP1 DNAH3 NAAA PI4K2A KMT2A

4.89e-051944755076_DN
Drugmonastrol; Up 200; 100uM; MCF7; HG-U133A

POMT2 AHI1 KIAA0232 SGSM3 ITPKB

5.01e-05195475596_UP
DrugPindolol [13523-86-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A

MFGE8 NAAA ELP1 KMT2A SLC13A3

5.01e-051954756834_UP
DrugPirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A

TMEM260 MFGE8 AHI1 KMT2A SGSM3

5.01e-051954752071_DN
Drugnordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A

FAM50B AHI1 ASPH PI4K2A WDFY3

5.14e-051964751164_DN
DrugGlycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A

BMP1 AHI1 PI4K2A KMT2A SLC13A3

5.14e-051964753315_UP
DrugSulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A

POMT2 MFGE8 B3GNT2 ASPH ERMP1

5.14e-051964751810_UP
Drug0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A

POMT2 AHI1 SGSM3 WDFY3 ITK

5.26e-051974757069_UP
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A

POMT2 BMP1 ASPH WDFY3 DCAF16

5.26e-051974756326_DN
DrugSulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A

POMT2 PI4K2A ELP1 KMT2A WDFY3

5.26e-051974751695_UP
DrugVitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A

B3GNT2 PI4K2A NTNG1 KMT2A NEB

5.26e-051974753798_DN
DrugCeforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A

POMT2 ASPH PI4K2A ELP1 ITPKB

5.26e-051974753309_DN
DrugSpaglumic acid [4910-46-7]; Up 200; 13.2uM; HL60; HT_HG-U133A

FAM50B BMP1 ASPH ELP1 SGSM3

5.39e-051984752962_UP
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A

POMT2 KIAA0232 B3GNT2 PI4K2A ITPKB

5.39e-051984756332_DN
DrugUrapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A

POMT2 BMP1 ASPH PI4K2A SGSM3

5.39e-051984755295_UP
DrugDiclofenac sodium [15307-79-6]; Up 200; 12.6uM; MCF7; HT_HG-U133A

NAAA PI4K2A SGSM3 NEB ITPKB

5.39e-051984757215_UP
DrugDoxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; PC3; HT_HG-U133A

FAM50B MFGE8 NAAA SCN9A NEB

5.39e-051984755838_UP
DrugOrnidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A

MFGE8 AHI1 KMT2A SGSM3 ACSS3

5.52e-051994752109_UP
Drug2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A

BMP1 KIAA0232 SCN9A PI4K2A SGSM3

5.65e-052004755750_DN
DrugGentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A

BMP1 DNAH3 ASPH SGSM3 NEB

5.65e-052004755883_DN
DrugFursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A

AHI1 ASPH PI4K2A GCGR NEB

5.65e-052004754975_UP
Drugpipobroman

NAAA KMT2A

1.86e-0410472CID000004842
DrugKM2210

NAAA KMT2A

1.86e-0410472CID000053181
DrugL 230

MFGE8 SGSM3

3.21e-0413472CID000737171
Drugtyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA

BPTF KIAA0232 B3GNT2 KMT2A

5.73e-041854741114_DN
DrugDiflorasone Diacetate [33564-31-7]; Up 200; 8uM; HL60; HT_HG-U133A

BMP1 ASPH PI4K2A SLC13A3

5.73e-041854742142_UP
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

KMT2A WDFY3 DCAF16 ITPKB

5.85e-041864743279_DN
DrugAlsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A

BMP1 DNAH3 ASPH SCN9A

6.09e-041884747056_UP
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

BPTF ASPH KMT2A DCAF16

6.09e-041884746735_DN
Drugphenazine-1-carboxylic acid

PTPN5 NAAA

6.25e-0418472CID000095069
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

ASPH NEB ITK ACSS3

6.46e-041914744279_DN
DrugTrifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

POMT2 AHI1 PI4K2A SGSM3

6.46e-041914745442_DN
DrugTranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A

POMT2 BPTF NAAA PI4K2A

6.46e-041914741417_UP
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A

FAM50B BMP1 B3GNT2 NEB

6.46e-041914742368_UP
DrugAntimycin A [1397-94-0]; Up 200; 7.2uM; MCF7; HT_HG-U133A

AHI1 ASPH PI4K2A KMT2A

6.58e-041924742261_UP
DrugTetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A

POMT2 DNAH3 AHI1 ITPKB

6.71e-041934746209_UP
DrugAlprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A

BMP1 PI4K2A ELP1 SGSM3

6.71e-041934746789_UP
DrugGabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A

MFGE8 NAAA PI4K2A NEB

6.71e-041934747229_UP
DrugLevodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A

BMP1 PI4K2A SGSM3 PARP12

6.71e-041934744394_DN
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A

B3GNT2 ASPH ERMP1 WDFY3

6.71e-041934746716_DN
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A

MFGE8 AHI1 ZNF549 ELP1

6.71e-041934746625_DN
DrugPropafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A

BMP1 NTNG1 KMT2A ITPKB

6.71e-041934745437_UP
DrugMethyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

FAM50B POMT2 ASPH KMT2A

6.71e-041934743943_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

POMT2 MFGE8 AHI1 ASPH

6.71e-041934744338_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A

POMT2 MFGE8 AHI1 ASPH

6.71e-041934743973_DN
DrugSulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

MFGE8 AHI1 NAAA SCN9A

6.84e-041944745732_DN
DrugTetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A

BMP1 PI4K2A SGSM3 ITPKB

6.84e-041944746769_UP
DrugColchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A

BMP1 MFGE8 PI4K2A SGSM3

6.84e-041944743213_UP
DrugLoxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A

BMP1 AHI1 SGSM3 ITPKB

6.84e-041944745293_UP
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A

NAAA ASPH PI4K2A ITPKB

6.84e-041944742221_DN
DrugOmeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A

FAM50B BMP1 WDFY3 NEB

6.84e-041944742467_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

BMP1 PI4K2A NEB PARP12

6.84e-041944741024_UP
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

BMP1 DNAH3 SGSM3 PARP12

6.84e-041944747001_DN
Drug2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A

BMP1 DNAH3 ASPH SGSM3

6.84e-041944743570_DN
DrugCefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A

POMT2 BMP1 PI4K2A WDFY3

6.98e-041954747394_UP
DrugDihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A

BMP1 AHI1 ASPH PI4K2A

6.98e-041954744502_DN
DrugTriflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A

POMT2 NAAA PI4K2A PARP12

6.98e-041954742867_DN
DrugBumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A

NAAA ASPH SGSM3 NEB

6.98e-041954742409_DN
DrugFluspirilen [1841-19-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A

POMT2 NAAA ASPH WDFY3

6.98e-041954745008_DN
DrugFuraltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A

POMT2 MFGE8 KMT2A ACSS3

6.98e-041954744313_UP
DrugFusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; PC3; HT_HG-U133A

POMT2 ASPH PI4K2A SGSM3

6.98e-041954746754_DN
Drugtetraethylenepentamine pentahydrochloride; Down 200; 10uM; MCF7; HG-U133A

MFGE8 KMT2A SLC13A3 ITPKB

6.98e-04195474405_DN
Drug5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA

NAAA ELP1 NEB PARP12

6.98e-04195474903_UP
DrugGBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A

POMT2 BMP1 AHI1 NEB

6.98e-041954745702_DN
DrugNalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A

AHI1 ASPH ELP1 ITPKB

6.98e-041954742336_DN
DrugChicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A

NAAA ASPH PI4K2A WDFY3

6.98e-041954743266_UP
DrugH-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A

MFGE8 NAAA SGSM3 NEB

6.98e-041954745941_UP
DrugPalmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A

NAAA ASPH PI4K2A WDFY3

6.98e-041954742795_UP
DrugSulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

NAAA ASPH PI4K2A KMT2A

6.98e-041954744740_DN
DrugChicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A

BMP1 DNAH3 ZNF549 SGSM3

6.98e-041954746626_DN
DrugDoxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A

BMP1 MFGE8 NAAA ELP1

6.98e-041954744235_DN
DrugGW8510; Up 200; 10uM; PC3; HT_HG-U133A

POMT2 BMP1 NAAA SGSM3

6.98e-041954747085_UP
DrugAconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A

PI4K2A KMT2A SGSM3 WDFY3

6.98e-041954742776_DN
DrugBufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A

FAM50B ASPH SGSM3 NEB

7.11e-041964742382_DN
DrugCefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; PC3; HT_HG-U133A

DNAH3 PI4K2A KMT2A ERMP1

7.11e-041964745868_DN
DrugEburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A

MFGE8 ASPH SGSM3 WDFY3

7.11e-041964742781_UP
DrugFelbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A

AHI1 PI4K2A WDFY3 NEB

7.11e-041964745700_DN
Drugpioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A

POMT2 BMP1 DNAH3 ITPKB

7.11e-041964747506_UP
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A

BMP1 DNAH3 NEB ITPKB

7.11e-041964743248_DN
DrugPhthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A

DNAH3 ASPH WDFY3 ITPKB

7.11e-041964745249_DN
DrugNaringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A

PI4K2A NTNG1 ELP1 KMT2A

7.11e-041964744597_UP
DrugKhellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A

BMP1 AHI1 PI4K2A NEB

7.11e-041964744987_DN
DrugAzaperone [1649-18-9]; Down 200; 12.2uM; PC3; HT_HG-U133A

FAM50B AHI1 ERMP1 SGSM3

7.11e-041964745877_DN
DrugSyrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A

FAM50B SCN9A SGSM3 WDFY3

7.11e-041964745733_DN
DrugAzlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A

FAM50B BMP1 WDFY3 NEB

7.11e-041964743468_DN
DrugEthambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

POMT2 B3GNT2 PI4K2A WDFY3

7.11e-041964744120_DN
DrugPrimidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A

BMP1 NAAA ASPH WDFY3

7.11e-041964745323_UP
DrugNomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A

POMT2 MFGE8 B3GNT2 WDFY3

7.11e-041964745863_UP
DrugClorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A

FAM50B POMT2 ASPH PI4K2A

7.11e-041964745005_DN
Drugbeta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A

BMP1 NAAA ZNF549 PI4K2A

7.11e-041964746638_DN
Drugradicicol; Down 200; 0.1uM; MCF7; HG-U133A

DNAH3 MFGE8 AHI1 SLC13A3

7.11e-04196474325_DN
Drug0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A

ASPH SCN9A SGSM3 ITK

7.11e-041964747102_UP
DrugFinasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A

POMT2 MFGE8 KMT2A SGSM3

7.11e-041964744766_DN
Diseaserespiratory system disease

AHI1 ERMP1 ITK ITPKB

7.78e-05145464EFO_0000684
Diseasenon-Hodgkin lymphoma (is_implicated_in)

TMEM260 KMT2A

3.19e-0417462DOID:0060060 (is_implicated_in)
DiseaseInflammatory Bowel Diseases

XIAP IL23R

1.37e-0335462C0021390

Protein segments in the cluster

PeptideGeneStartEntry
HKHKKLQSFYPWEWG

ERVK-9

301

Q9UKH3
KDLWKHSFSWPFQRP

BRDT

41

Q58F21
SNSSYLKWNKPVPWL

B4GALNT3

101

Q6L9W6
SPPGPYWTHVLFTWK

ADGRD1

161

Q6QNK2
EWWSKCPRNHYPSTL

AHI1

516

Q8N157
KAQPWWTPKETGYTE

ASPH

571

Q12797
PNWPDKYPSKKECTW

BMP1

761

P13497
TWVKYTFPVKHQVWK

BPTF

1006

Q12830
KYSTTWKPLNPNSWL

DCAF16

61

Q9NXF7
WKPLNPNSWLYHAKL

DCAF16

66

Q9NXF7
ALKEKFPDWTFPSAW

ERMP1

881

Q7Z2K6
LKHYWFTSWPDQKTP

PTPN5

451

P54829
HPAWYGDTLKQKTSW

KIAA0100

1611

Q14667
SYKTWGLHLFSWNPS

MFGE8

251

Q08431
WFRVETNYDHWKPAP

NAAA

281

Q02083
TWWEKALYSPLFPAS

KIAA0232

1286

Q92628
TANISCPWYLPWHHK

GCGR

76

P47871
WWSQPYQPHTCLKST

MPP4

316

Q96JB8
YLWESPSLAIKPWKN

ELP1

581

O95163
QFPSPSWYWDTVTKI

OPRD1

201

P41143
TKPPHFILTTDWIWY

PARP12

366

Q9H0J9
EEPYGHLNPKWTKWL

PI4K2A

156

Q9BTU6
WHYKFADTRPWDPLN

OSBPL8

741

Q9BZF1
TPSPWAENQFWHKPY

IGSF10

1566

Q6WRI0
PVPWHSVYRSAKKWN

DNAH3

326

Q8TD57
HKHKKLQSFYPWEWG

ERVK-24

191

P61566
HKHKKLQSFYPWEWG

ERVK-7

191

P61567
KRYWQPWSSLFFHKT

IL23R

301

Q5VWK5
HKHKKLQSFYPWEWG

ERVK-21

301

P61565
HKHKKLQSFYPWEWG

ERVK-5

191

Q9HDB8
LSKKPWWTLPQNFHA

KHDC1

81

Q4VXA5
FPWFSVKKSRFWEPN

KMT2A

1766

Q03164
WTSFEDKLPKSWRYP

DNAH2

2366

Q9P225
RPSLKWWFDFKAPNT

SLC13A3

396

Q8WWT9
KSWSEEKWHYLFPAP

R3HDML

136

Q9H3Y0
LVPKYHPNFWMDGKW

ITK

116

Q08881
TFWQSATWKEYPKPL

NTNG1

116

Q9Y2I2
LKPKDNEFTSKPWHW

POMT2

556

Q9UKY4
NEFTSKPWHWPINYQ

POMT2

561

Q9UKY4
HWSPFVMSFKKKYPW

ITPKB

656

P27987
SSLPTVEKWYQPWSF

SGSM3

676

Q96HU1
SRQKCPPWWYRFAHK

SCN9A

706

Q15858
HVKPPQFTWAQWFET

RNASE2

26

P10153
KWIDIKQFVWYTPPT

STEAP1

276

Q9UHE8
EKFWKISTPPEAYWN

B3GNT2

46

Q9NY97
WYKPWTKTLENKHSP

ACSS3

86

Q9H6R3
LPWQKPYTSVASGKW

ZNF549

126

Q6P9A3
KPSEDPWEQHAKWYP

XIAP

311

P98170
LIPPTWNKTFAWGYA

WDFY3

3041

Q8IZQ1
KPWTAVQKSHYTIWD

TREML4

71

Q6UXN2
KYFPEKFEWLPISSW

USP40

1121

Q9NVE5
HEGDPTWKKNYSLWP

TMEM260

526

Q9NX78
SWYEKNKHIFPASRW

FAM50B

296

Q9Y247
FPALWFLAKKPWTEY

NAT8

71

Q9UHE5
YEANKAHWKWTPDRP

NEB

5551

P20929